Trinity Biotech PLC (TRIB)
1.30
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
1.30
0.00 (0.00%)
After-Hours: 07:05
Trinity Biotech Enterprise Value: 91.30M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 91.30M |
| November 20, 2024 | 91.30M |
| November 19, 2024 | 91.49M |
| November 18, 2024 | 91.29M |
| November 15, 2024 | 91.96M |
| November 14, 2024 | 93.00M |
| November 13, 2024 | 93.66M |
| November 12, 2024 | 94.23M |
| November 11, 2024 | 94.42M |
| November 08, 2024 | 94.23M |
| November 07, 2024 | 94.89M |
| November 06, 2024 | 94.80M |
| November 05, 2024 | 95.37M |
| November 04, 2024 | 94.99M |
| November 01, 2024 | 94.99M |
| October 31, 2024 | 95.65M |
| October 30, 2024 | 96.69M |
| October 29, 2024 | 98.11M |
| October 28, 2024 | 99.82M |
| October 25, 2024 | 97.26M |
| October 24, 2024 | 96.31M |
| October 23, 2024 | 93.66M |
| October 22, 2024 | 93.66M |
| October 21, 2024 | 94.42M |
| October 18, 2024 | 95.18M |
| Date | Value |
|---|---|
| October 17, 2024 | 95.60M |
| October 16, 2024 | 95.84M |
| October 15, 2024 | 94.91M |
| October 14, 2024 | 95.27M |
| October 11, 2024 | 97.92M |
| October 10, 2024 | 96.12M |
| October 09, 2024 | 95.37M |
| October 08, 2024 | 93.71M |
| October 07, 2024 | 91.87M |
| October 04, 2024 | 90.35M |
| October 03, 2024 | 89.97M |
| October 02, 2024 | 90.16M |
| October 01, 2024 | 90.07M |
| September 30, 2024 | 89.40M |
| September 27, 2024 | 85.98M |
| September 26, 2024 | 86.55M |
| September 25, 2024 | 86.93M |
| September 24, 2024 | 87.50M |
| September 23, 2024 | 87.50M |
| September 20, 2024 | 87.69M |
| September 19, 2024 | 87.78M |
| September 18, 2024 | 89.86M |
| September 17, 2024 | 90.81M |
| September 16, 2024 | 91.00M |
| September 13, 2024 | 90.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
62.58M
Minimum
Nov 27 2023
197.06M
Maximum
Feb 16 2021
98.07M
Average
95.49M
Median
Apr 28 2020
Enterprise Value Benchmarks
| Amarin Corp PLC | -89.82M |
| DBV Technologies SA | 1.221M |
| Ascendis Pharma AS | 7.511B |
| Cellectis SA | -28.39M |
| Adaptimmune Therapeutics PLC | 26.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.759M |
| Revenue (Quarterly) | 15.15M |
| Total Expenses (Quarterly) | 17.37M |
| EPS Diluted (Quarterly) | -0.46 |
| Gross Profit Margin (Quarterly) | 35.03% |
| Profit Margin (Quarterly) | -31.41% |
| Earnings Yield | -175.4% |
| Normalized Earnings Yield | -165.32 |